June 16, 2024

Moderna logo

The FDA just approved Moderna’s second-ever product.
Image: Dado Ruvic (Reuters)

The Food and Drug Administration on Friday approved Moderna’s mRNA-based respiratory syncytial virus (RSV) vaccine for people 60 and older. The approval paves the way for the pharma giant, known for its COVID-19 vaccine, to launch its second-ever product. 

Read More

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *